LADENBURG THALMANN FINANCIAL SERVICES INC. - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 39 filers reported holding CYTOSORBENTS CORP in Q4 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q4 2019$7,000
-36.4%
1,800
-17.6%
0.00%
Q3 2019$11,000
+120.0%
2,185
+173.1%
0.00%
Q2 2019$5,000
-28.6%
8000.0%0.00%
Q1 2019$7,000
-58.8%
800
-61.4%
0.00%
Q4 2018$17,000
-37.0%
2,0700.0%0.00%
Q3 2018$27,000
+92.9%
2,0700.0%0.00%
Q2 2018$14,0000.0%2,0700.0%0.00%
Q1 2018$14,000
+75.0%
2,070
+72.5%
0.00%
Q4 2017$8,000
-96.7%
1,200
-96.9%
0.00%
-100.0%
Q3 2017$242,000
+42.4%
39,100
-1.3%
0.00%
+50.0%
Q2 2017$170,000
-10.5%
39,600
-6.1%
0.00%0.0%
Q1 2017$190,000
-19.5%
42,169
-2.7%
0.00%
-33.3%
Q4 2016$236,000
-18.9%
43,319
-4.6%
0.00%
-25.0%
Q3 2016$291,000
+164.5%
45,419
+88.7%
0.00%
+100.0%
Q2 2016$110,000
+18.3%
24,069
+2.0%
0.00%0.0%
Q1 2016$93,000
-13.1%
23,600
+23.0%
0.00%0.0%
Q4 2015$107,00019,1810.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2015
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 964,141$7,829,0001.90%
Skylands Capital, LLC 1,837,541$14,921,0001.84%
CM Management, LLC 175,000$1,421,0001.06%
Soleus Capital Management, L.P. 800,000$6,496,0001.01%
Avenir Corp 1,395,385$11,331,0000.95%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 185,000$1,502,0000.55%
Winning Points Advisors, LLC 86,200$701,0000.51%
Granahan Investment Management 1,154,561$9,375,0000.18%
SECTORAL ASSET MANAGEMENT INC 244,660$1,987,0000.16%
Redmile Group, LLC 1,044,434$8,481,0000.15%
View complete list of CYTOSORBENTS CORP shareholders